Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma

We have monitored Epstein–Barr virus (EBV) IgA antibody levels of 39 nasopharyngeal carcinoma (NPC) cases for up to 15 years before clinical onset of NPC, and assessed preclinical serologic status of another 68 cases. Our results identify a serologic window preceding diagnosis when antibody levels a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, M F, Wang, D K, Yu, Y L, Guo, Y Q, Liang, J S, Cheng, W M, Zong, Y S, Chan, K H, Ng, S P, Wei, W I, Chua, D T T, Sham, J S T, Ng, M H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360049/
https://www.ncbi.nlm.nih.gov/pubmed/17285127
http://dx.doi.org/10.1038/sj.bjc.6603609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360049/
https://www.ncbi.nlm.nih.gov/pubmed/17285127
http://dx.doi.org/10.1038/sj.bjc.6603609

Ejemplares similares